|
What's the deal with Zenith?
|
3
|
Zenith Epigenetics
|
Jun 21, 2023 04:54PM
|
|
What an incredible...
|
7
|
Resverlogix Corp.
|
Dec 22, 2019 11:27AM
|
|
Volume
|
2
|
Resverlogix Corp.
|
Mar 15, 2021 11:04AM
|
|
Update from IR -- Eversana paused?
|
4
|
Resverlogix Corp.
|
Dec 16, 2022 08:18PM
|
|
The most promising claims made
|
10
|
Resverlogix Corp.
|
May 14, 2021 06:52PM
|
|
The Hepa Link?
|
2
|
Resverlogix Corp.
|
Jan 12, 2020 10:28PM
|
|
Sounds like great news!
|
4
|
Resverlogix Corp.
|
Feb 18, 2020 03:06PM
|
|
Something brewing?
|
8
|
Resverlogix Corp.
|
Jan 25, 2021 02:29PM
|
|
Sneaking Suspicion...
|
6
|
Resverlogix Corp.
|
Feb 04, 2021 12:00PM
|
|
Short squeeze?
|
7
|
Resverlogix Corp.
|
Jan 19, 2022 11:44AM
|
|
Short position
|
|
Resverlogix Corp.
|
Jan 29, 2021 01:08AM
|
|
Resverlogix announces HEPALINK debenture $6mill
|
8
|
Resverlogix Corp.
|
May 05, 2021 10:06AM
|
|
Re: What if
|
7
|
Resverlogix Corp.
|
Jul 15, 2022 12:11PM
|
|
Re: Value
|
6
|
Resverlogix Corp.
|
Mar 14, 2020 09:27PM
|
|
Re: Update
|
10
|
Resverlogix Corp.
|
Dec 17, 2021 11:20AM
|
|
Re: Update
|
6
|
Resverlogix Corp.
|
Dec 17, 2021 01:05PM
|
|
Re: Two Interesting Articles - 2 of 2: COVID-19: consider cytokine storm syndromes and immunosuppression
|
2
|
Resverlogix Corp.
|
Apr 13, 2020 08:10PM
|
|
Re: Two Interesting Articles - 2 of 2: COVID-19: consider cytokine storm syndromes and immunosuppression
|
3
|
Resverlogix Corp.
|
Apr 15, 2020 09:51AM
|
|
Re: Trial delay
|
3
|
Resverlogix Corp.
|
May 04, 2021 05:47PM
|
|
Re: Time keeps ticking
|
4
|
Resverlogix Corp.
|
Nov 17, 2021 06:05PM
|
